Relative risk reduction

From Citizendium
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In clinical epidemiology and evidence-based medicine, the relative risk reduction is a measure of the likelihood of a clinical outcome in group of patients exposed to a factor compared to a control group of patients.[1] This measure should be contrasted with the absolute risk reduction.

Calculations

Two-by-two table for a randomized-controlled trial or cohort study
Outcome
Present Absent
Experimental group Cell A Cell B Total in the experimental group
Control group Cell C Cell D Total in the control group
Total with the outcome Total without the outcome

The relative risk reduction may be used to derive the number needed to treat:[2][3]

Note that the relative risk reduction is that same as 1 - the relative risk ratio.

References

  1. Barratt A, Wyer PC, Hatala R, et al (2004). "Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat". CMAJ 171 (4): 353–8. DOI:10.1503/cmaj.1021197. PMID 15313996. Research Blogging.
  2. Furukawa TA, Guyatt GH, Griffith LE (February 2002). "Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses". Int J Epidemiol 31 (1): 72–6. PMID 11914297[e]
  3. Chatellier G, Zapletal E, Lemaitre D, Menard J, Degoulet P (February 1996). "The number needed to treat: a clinically useful nomogram in its proper context". BMJ 312 (7028): 426–9. PMID 8601116. PMC 2350093[e]

See also